A detailed history of Blair William & CO transactions in Twist Bioscience Corp stock. As of the latest transaction made, Blair William & CO holds 21,708 shares of TWST stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,708
Previous 23,358 7.06%
Holding current value
$1.17 Million
Previous $860,000 13.49%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$32.28 - $41.5 $53,262 - $68,475
-1,650 Reduced 7.06%
21,708 $744,000
Q4 2023

Feb 12, 2024

SELL
$15.08 - $38.61 $28,802 - $73,745
-1,910 Reduced 7.56%
23,358 $860,000
Q3 2023

Nov 09, 2023

SELL
$18.62 - $26.57 $34,260 - $48,888
-1,840 Reduced 6.79%
25,268 $511,000
Q2 2023

Aug 11, 2023

SELL
$11.49 - $20.46 $204,476 - $364,106
-17,796 Reduced 39.63%
27,108 $554,000
Q1 2023

May 12, 2023

SELL
$14.6 - $30.9 $440,803 - $932,932
-30,192 Reduced 40.2%
44,904 $677,000
Q4 2022

Feb 10, 2023

BUY
$21.92 - $39.37 $1.48 Million - $2.65 Million
67,335 Added 867.61%
75,096 $1.79 Million
Q3 2022

Nov 09, 2022

SELL
$33.44 - $56.56 $77,580 - $131,219
-2,320 Reduced 23.01%
7,761 $273,000
Q2 2022

Aug 10, 2022

BUY
$26.2 - $54.0 $83,001 - $171,072
3,168 Added 45.83%
10,081 $352,000
Q1 2022

May 13, 2022

BUY
$38.58 - $83.27 $40,200 - $86,767
1,042 Added 17.75%
6,913 $341,000
Q4 2021

Feb 14, 2022

BUY
$75.47 - $135.88 $132,902 - $239,284
1,761 Added 42.85%
5,871 $454,000
Q3 2021

Nov 12, 2021

BUY
$95.64 - $131.48 $188,506 - $259,147
1,971 Added 92.15%
4,110 $440,000
Q2 2021

Aug 12, 2021

SELL
$88.13 - $142.06 $10,751 - $17,331
-122 Reduced 5.4%
2,139 $285,000
Q1 2021

May 13, 2021

SELL
$105.48 - $207.97 $2,004 - $3,951
-19 Reduced 0.83%
2,261 $280,000
Q4 2020

Feb 09, 2021

BUY
$76.64 - $167.89 $174,739 - $382,789
2,280 New
2,280 $322,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $3.04B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.